Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4).
Bieber T, Reich K, Paul C, Tsunemi Y, Augustin M, Lacour JP, Ghislain PD, Dutronc Y, Liao R, Yang FE, Brinker D, DeLozier AM, Meskimen E, Janes JM, Eyerich K; BREEZE-AD4 study group. Bieber T, et al. Among authors: tsunemi y. Br J Dermatol. 2022 Sep;187(3):338-352. doi: 10.1111/bjd.21630. Epub 2022 Jul 20. Br J Dermatol. 2022. PMID: 35484697 Clinical Trial.
Prevalence of atopic dermatitis in Japanese elementary schoolchildren.
Saeki H, Iizuka H, Mori Y, Akasaka T, Takagi H, Kitajima Y, Tezuka T, Tanaka T, Hide M, Yamamoto S, Hirose Y, Kodama H, Urabe K, Furue M, Kasagi F, Torii H, Nakamura K, Morita E, Tsunemi Y, Tamaki K. Saeki H, et al. Among authors: tsunemi y. Br J Dermatol. 2005 Jan;152(1):110-4. doi: 10.1111/j.1365-2133.2004.06271.x. Br J Dermatol. 2005. PMID: 15656810
Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients.
Saeki H, Imafuku S, Abe M, Shintani Y, Onozuka D, Hagihara A, Katoh N, Murota H, Takeuchi S, Sugaya M, Tanioka M, Kaneko S, Masuda K, Hiragun T, Inomata N, Kitami Y, Tsunemi Y, Abe S, Kobayashi M, Morisky DE, Furue M. Saeki H, et al. Among authors: tsunemi y. J Dermatol. 2015 Apr;42(4):367-72. doi: 10.1111/1346-8138.12804. Epub 2015 Feb 27. J Dermatol. 2015. PMID: 25720544
Twelve-week, multicenter, placebo-controlled, randomized, double-blind, parallel-group, comparative phase II/III study of benzoyl peroxide gel in patients with acne vulgaris: A secondary publication.
Kawashima M, Sato S, Furukawa F, Matsunaga K, Akamatsu H, Igarashi A, Tsunemi Y, Hayashi N, Yamamoto Y, Nagare T, Katsuramaki T. Kawashima M, et al. Among authors: tsunemi y. J Dermatol. 2017 Jul;44(7):774-782. doi: 10.1111/1346-8138.13798. Epub 2017 Mar 11. J Dermatol. 2017. PMID: 28295516 Free PMC article. Clinical Trial.
Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.
Simpson EL, Lacour JP, Spelman L, Galimberti R, Eichenfield LF, Bissonnette R, King BA, Thyssen JP, Silverberg JI, Bieber T, Kabashima K, Tsunemi Y, Costanzo A, Guttman-Yassky E, Beck LA, Janes JM, DeLozier AM, Gamalo M, Brinker DR, Cardillo T, Nunes FP, Paller AS, Wollenberg A, Reich K. Simpson EL, et al. Among authors: tsunemi y. Br J Dermatol. 2020 Aug;183(2):242-255. doi: 10.1111/bjd.18898. Epub 2020 Mar 5. Br J Dermatol. 2020. PMID: 31995838
Current treatments for atopic dermatitis in Japan.
Miyano K, Tsunemi Y. Miyano K, et al. Among authors: tsunemi y. J Dermatol. 2021 Feb;48(2):140-151. doi: 10.1111/1346-8138.15730. Epub 2020 Dec 30. J Dermatol. 2021. PMID: 33377547 Review.
English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021.
Saeki H, Ohya Y, Furuta J, Arakawa H, Ichiyama S, Katsunuma T, Katoh N, Tanaka A, Tsunemi Y, Nakahara T, Nagao M, Narita M, Hide M, Fujisawa T, Futamura M, Masuda K, Matsubara T, Murota H, Yamamoto-Hanada K. Saeki H, et al. Among authors: tsunemi y. J Dermatol. 2022 Oct;49(10):e315-e375. doi: 10.1111/1346-8138.16527. Epub 2022 Aug 22. J Dermatol. 2022. PMID: 35996152
English version of Japanese guidance for the use of oral Janus kinase (JAK) inhibitors in the treatments of atopic dermatitis.
Saeki H, Akiyama M, Abe M, Igarashi A, Imafuku S, Ohya Y, Katoh N, Kameda H, Kabashima K, Tsunemi Y, Hide M, Ohtsuki M; Committee for reviewing the Safety of Atopic Dermatitis/Urticaria Treatment, Japanese Dermatological Association. Saeki H, et al. Among authors: tsunemi y. J Dermatol. 2023 Jan;50(1):e1-e19. doi: 10.1111/1346-8138.16635. Epub 2022 Nov 22. J Dermatol. 2023. PMID: 36412059
170 results